Literature DB >> 11444379

Genetic and structural determinants of virus neutralizing antibodies.

J E Crowe1, R O Suara, S Brock, N Kallewaard, F House, J H Weitkamp.   

Abstract

Neutralizing antibodies (Abs) are the principal protective mechanism against disease caused by reinfection with viruses. Ab-mediated neutralization of viruses is a complex process comprising multiple mechanisms. Every structural aspect of Abs is potentially capable of modulating the level of neutralizing activity or the mechanisms of neutralization. The focus of our laboratory is to understand the genetic and structural basis of Ab-mediated neutralization of human viral pathogens. We demonstrated the unexpected finding that virus antigen-binding fragments of Abs (Fabs) mediate potent virus neutralizing effects in vivo. This work has led to a broad investigation of the importance of the genetics, chemistry, and structure of the combining site to the neutralizing activity of antiviral Abs. Ongoing work in our laboratory reveals that effect or functions specified by the Ab isotype such as polymer formation, interactions with complement, interactions with Fc receptors, and the ability to transcytose mucosal epithelia, also modulate the mechanism and level of neutralizing effects mediated by antiviral Abs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11444379     DOI: 10.1385/IR:23:2-3:135

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  53 in total

1.  Electron microscopy of the human respiratory syncytial virus fusion protein and complexes that it forms with monoclonal antibodies.

Authors:  L J Calder; L González-Reyes; B García-Barreno; S A Wharton; J J Skehel; D C Wiley; J A Melero
Journal:  Virology       Date:  2000-05-25       Impact factor: 3.616

2.  Intracellular neutralization of virus by immunoglobulin A antibodies.

Authors:  M B Mazanec; C S Kaetzel; M E Lamm; D Fletcher; J G Nedrud
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

3.  Is bivalent binding of monoclonal antibodies to different antigenic areas on the hemagglutinin of influenza virus required for neutralization of viral infectivity?

Authors:  S Yoden; H Kida; R Yanagawa
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

4.  In vitro evolution of a neutralizing human antibody to human immunodeficiency virus type 1 to enhance affinity and broaden strain cross-reactivity.

Authors:  C F Barbas; D Hu; N Dunlop; L Sawyer; D Cababa; R M Hendry; P L Nara; D R Burton
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

5.  Rates of spontaneous mutation among RNA viruses.

Authors:  J W Drake
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

6.  Structural characterization of broadly neutralizing human monoclonal antibodies against the CD4 binding site of HIV-1 gp120.

Authors:  J Bagley; P J Dillon; C Rosen; J Robinson; J Sodroski; W A Marasco
Journal:  Mol Immunol       Date:  1994-10       Impact factor: 4.407

7.  Early high-affinity neutralizing anti-viral IgG responses without further overall improvements of affinity.

Authors:  H P Roost; M F Bachmann; A Haag; U Kalinke; V Pliska; H Hengartner; R M Zinkernagel
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

8.  Isolation of a second recombinant human respiratory syncytial virus monoclonal antibody fragment (Fab RSVF2-5) that exhibits therapeutic efficacy in vivo.

Authors:  J E Crowe; P S Gilmour; B R Murphy; R M Chanock; L Duan; R J Pomerantz; G R Pilkington
Journal:  J Infect Dis       Date:  1998-04       Impact factor: 5.226

9.  Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity.

Authors:  J W Burns; M Siadat-Pajouh; A A Krishnaney; H B Greenberg
Journal:  Science       Date:  1996-04-05       Impact factor: 47.728

10.  Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats.

Authors:  G A Prince; R L Horswood; R M Chanock
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

View more
  4 in total

1.  Sindbis virus conformational changes induced by a neutralizing anti-E1 monoclonal antibody.

Authors:  Raquel Hernandez; Angel Paredes; Dennis T Brown
Journal:  J Virol       Date:  2008-04-16       Impact factor: 5.103

2.  Probing the flavivirus membrane fusion mechanism by using monoclonal antibodies.

Authors:  Karin Stiasny; Samantha Brandler; Christian Kössl; Franz X Heinz
Journal:  J Virol       Date:  2007-08-01       Impact factor: 5.103

3.  Surveillance of SARS-CoV-2 antibodies of patients in the local affected area during Wuhan lockdown.

Authors:  Yueting Tang; Jiayu Sun; Yumeng Yuan; Fen Yao; Bokun Zheng; Gui Yang; Wen Xie; Guangming Ye; Zhen Li; Xiaoyang Jiao; Yirong Li
Journal:  BMC Infect Dis       Date:  2022-01-04       Impact factor: 3.090

4.  Neutralizing antibodies in patients with severe acute respiratory syndrome-associated coronavirus infection.

Authors:  Yuchun Nie; Guangwen Wang; Xuanling Shi; Hong Zhang; Yan Qiu; Zhongping He; Wei Wang; Gewei Lian; Xiaolei Yin; Liying Du; Lili Ren; Jianwei Wang; Xiong He; Taisheng Li; Hongkui Deng; Mingxiao Ding
Journal:  J Infect Dis       Date:  2004-08-02       Impact factor: 5.226

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.